ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, a biopharmaceutical company focused on severe allergic reactions, announced that CEO Richard Lowenthal and CCO Eric Karas will speak at the SVB Securities Virtual Global Biopharma Conference on February 16, 2023, at 2:20 p.m. ET. A live webcast will be accessible on the company's investor website and will be archived for 30 days post-event. The company is known for developing neffy®, an intranasal epinephrine product for patients at risk of anaphylaxis from allergies to foods, medications, and insect bites.
- None.
- None.
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today reported that Richard Lowenthal, M.Sc., MSEL, co-founder and chief executive officer, and Eric Karas, chief commercial officer, will participate in a fireside chat during the SVB Securities Virtual Global Biopharma Conference 2023 on Thursday, February 16, 2023 at 2:20 p.m. ET.
A live webcast will be available in the investor section of the company’s website at www.ars-pharma.com. The webcast will be archived for 30 days following the presentation.
About ARS Pharmaceuticals, Inc.
ARS is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The Company is developing neffy® (previously referred to as ARS-1), an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications and insect bites that could lead to life-threatening anaphylaxis. For more information, visit www.ars-pharma.com.
ARS Investor Contact:
Justin Chakma
ARS Pharmaceuticals
justinc@ars-pharma.com
FAQ
What is the date and time of ARS Pharmaceuticals' presentation at the SVB Securities Conference?
Where can I watch the ARS Pharmaceuticals' conference presentation?
What product is ARS Pharmaceuticals developing for allergic reactions?
Who are the speakers at the SVB Securities Conference representing ARS Pharmaceuticals?
How long will the webcast of the ARS Pharmaceuticals presentation be available?
